Unity Biotechnology
Stock Forecast, Prediction & Price Target
Unity Biotechnology Financial Estimates
Unity Biotechnology Revenue Estimates
Unity Biotechnology EBITDA Estimates
Unity Biotechnology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.78M N/A | $236K -95.06% | $0 -100% | Avg: $2.5M Low: $2.5M High: $2.5M avg. 0% | Avg: $25.72M Low: $25.72M High: $25.72M avg. 928.98% | Avg: $56.12M Low: $56.12M High: $56.12M avg. 118.18% | Avg: $84.86M Low: $84.86M High: $84.86M avg. 51.21% |
Net Income
% change YoY
| $-60.03M N/A | $-57.74M 3.81% | $-39.86M 30.97% | Avg: $-29.43M Low: $-29.43M High: $-29.43M avg. 26.15% | Avg: $-16.44M Low: $-16.44M High: $-16.44M avg. 44.13% | Avg: $886.41K Low: $886.41K High: $886.41K avg. 105.39% | Avg: $8.86M Low: $8.86M High: $8.86M avg. 900.00% |
EBITDA
% change YoY
| $-57.54M N/A | $-56.36M 2.04% | $-37.28M 33.85% | Avg: $499.99K Low: $499.99K High: $499.99K avg. 101.34% | Avg: $5.14M Low: $5.14M High: $5.14M avg. 928.98% | Avg: $11.22M Low: $11.22M High: $11.22M avg. 118.18% | Avg: $16.97M Low: $16.97M High: $16.97M avg. 51.21% |
EPS
% change YoY
| -$10.76 N/A | -$6.08 43.49% | -$2.7 55.59% | Avg: -$1.99 Low: -$1.99 High: -$1.99 avg. 26.20% | Avg: -$1.11 Low: -$1.11 High: -$1.11 avg. 44.13% | Avg: $0.06 Low: $0.06 High: $0.06 avg. 105.39% | Avg: $0.6 Low: $0.6 High: $0.6 avg. 900.00% |
Operating Expenses
% change YoY
| $61.44M N/A | $57.80M -5.92% | $44.66M -22.73% | Avg: $48.29M Low: $48.29M High: $48.29M avg. 8.11% | Avg: $496.92M Low: $496.92M High: $496.92M avg. 928.98% | Avg: $1.08B Low: $1.08B High: $1.08B avg. 118.18% | Avg: $1.63B Low: $1.63B High: $1.63B avg. 51.21% |
FAQ
What is Unity Biotechnology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 268.92% in 2025-2028.
We have gathered data from N/A analysts. Their low estimate is -29.43M, average is -29.43M and high is -29.43M.
What is Unity Biotechnology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 274.59% in 2025-2028.
We have gathered data from N/A analysts. Their low revenue estimate is $2.5M, average is $2.5M and high is $2.5M.
What is Unity Biotechnology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 268.93% in 2025-2028.
We have gathered data from N/A analysts. Their low earnings per share estimate is -$1.99, average is -$1.99 and high is $-1.99.